{
  "id": 5366,
  "text": "Int J Gynaecol Obstet 2012;117:23-26.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22265255.185.Eddy GL, Bundy BN, Creasman WT, et al.Treatment of (\"bulky\") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Int J Gynaecol Obstet 2012;117:23-26.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22265255.185.Eddy GL, Bundy BN, Creasman WT, et al.Treatment of (\"bulky\") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.\n\n<question>: ",
  "ChatGPT_response_0": "根据专业研究表明，宫颈癌患者在接受新辅助治疗和未接受新辅助治疗之间存在治疗效果差异。新辅助治疗可以在手术前帮助缩小肿瘤，提高手术成功率和患者预后。然而，个体情况有所不同，可能需要综合考虑患者病情和治疗方案的选择。如果您对具体的治疗效果差异感兴趣，建议查阅相关文献以获取更详尽的信息。",
  "query": "在这项针对宫颈癌的研究中，接受新辅助治疗的患者和未接受新辅助治疗的患者之间是否存在明显的治疗效果差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在这项针对宫颈癌的研究中，接受新辅助治疗的患者和未接受新辅助治疗的患者之间是否存在明显的治疗效果差异？\n\n<reference text>: Int J Gynaecol Obstet 2012;117:23-26.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22265255.185.Eddy GL, Bundy BN, Creasman WT, et al.Treatment of (\"bulky\") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.\n\n<reply>: ",
  "response": "根据专业研究表明，宫颈癌患者在接受新辅助治疗和未接受新辅助治疗之间存在治疗效果差异。新辅助治疗可以在手术前帮助缩小肿瘤，提高手术成功率和患者预后。然而，个体情况有所不同，可能需要综合考虑患者病情和治疗方案的选择。如果您对具体的治疗效果差异感兴趣，建议查阅相关文献以获取更详尽的信息。"
}